Literature DB >> 2446964

Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.

C Niederau1, R A Liddle, J A Williams, J H Grendell.   

Abstract

The effects on pancreatic growth and plasma CCK concentration of chronic feeding of camostate (400 mg/kg day for 10 days), a potent inhibitor of serine proteases including trypsin, were assessed in the mouse. For comparison, the trophic effects of chronic exogenous administration of CCK octapeptide (sc injection of 1 microgram/kg day every eight hours for 10 days) were also studied. In addition, the effects of a proglumide-analogue CCK-receptor antagonist (CR1409) on the stimulatory actions of camostate feeding and chronic administration of exogenous CCK were studied. The effects of the combination of chronic camostate feeding and sc injections of CCK, the effects of acute camostate feeding, and the effects of the CCK-receptor antagonist given without camostate or CCK were also studied. The results show that chronic camostate feeding markedly increased CCK plasma concentrations eight-fold over control values, and that acute camostate feeding increased plasma concentration to four fold of control values. Correspondingly, chronic camostate feeding markedly increased pancreatic weight, protein and DNA content. Exogenous CCK-8 also had qualitatively similar, but quantitatively less potent stimulatory effects. The combination of camostate and CCK-8 resulted in an additive stimulatory effect. The trophic actions of exogenous and endogenous CCK grossly increased chymotrypsinogen content, but left amylase content unaffected. The CCK-receptor antagonist CR 1409 completely abolished the trophic effects of exogenous CCK and greatly inhibited the effects of chronic camostate feeding. The CCK antagonist decreased pancreatic weight, DNA and protein content compared to control values when given without any CCK or camostate. We conclude that the protease inhibitor camostate is a very strong release effector of CCK and exerts a powerful trophic effect on mouse pancreas which is probably mediated by CCK. Furthermore, physiological increases of CCK during feeding of regular chow appear to exert trophic effects on the exocrine pancreas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446964      PMCID: PMC1434558          DOI: 10.1136/gut.28.suppl.63

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Reversible gastric and pancreatic hyposecretion after long-term total parenteral nutrition.

Authors:  D P Kotler; G M Levine
Journal:  N Engl J Med       Date:  1979-02-01       Impact factor: 91.245

2.  A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

Authors:  B C HUMMEL
Journal:  Can J Biochem Physiol       Date:  1959-12

3.  Effect of long-term parenteral feeding on pancreatic secretion and serum secretin.

Authors:  L R Johnson; L M Schanbacher; S J Dudrick; E M Copeland
Journal:  Am J Physiol       Date:  1977-12

4.  Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats.

Authors:  G M Green; R L Lyman
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

5.  A simple, rapid, and sensitive DNA assay procedure.

Authors:  C Labarca; K Paigen
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

6.  Requirements for activation of trypsinogen and chymotrypsinogen in rabbit pancreatic juice.

Authors:  G Glazer; M L Steer
Journal:  Anal Biochem       Date:  1977-01       Impact factor: 3.365

Review 7.  Small bowel adaptation and its regulation.

Authors:  R H Dowling
Journal:  Scand J Gastroenterol Suppl       Date:  1982

8.  Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin.

Authors:  A B Dembinski; L R Johnson
Journal:  Endocrinology       Date:  1980-01       Impact factor: 4.736

9.  Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat.

Authors:  U R Fölsch; K Winckler; K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

10.  Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol.

Authors:  R A Liddle; I D Goldfine; J A Williams
Journal:  Gastroenterology       Date:  1984-09       Impact factor: 22.682

View more
  20 in total

1.  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

Authors:  Jaroslaw Daniluk; Yan Liu; Defeng Deng; Jun Chu; Haojie Huang; Sebastian Gaiser; Zobeida Cruz-Monserrate; Huamin Wang; Baoan Ji; Craig D Logsdon
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Role of cholecystokinin in pancreatic adaptation to massive enterectomy.

Authors:  P Watanapa; M Egan; P H Deprez; J Calam; C E Sarraf; M R Alison; R C Williamson
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Molecular mechanisms of pancreatic dysfunction induced by protein malnutrition.

Authors:  Stephen J Crozier; Louis G D'Alecy; Stephen A Ernst; Lauren E Ginsburg; John A Williams
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

4.  Profiling CCK-mediated pancreatic growth: the dynamic genetic program and the role of STATs as potential regulators.

Authors:  Grzegorz T Gurda; Jackie Y Wang; LiLi Guo; Stephen A Ernst; John A Williams
Journal:  Physiol Genomics       Date:  2011-10-18       Impact factor: 3.107

Review 5.  The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.

Authors:  Venu Gopal Jonnalagadda; Allam Venkata Sita Ram Raju; Srinivas Pittala; Afsar Shaik; Nilakash Annaji Selkar
Journal:  Adv Pharm Bull       Date:  2014-02-07

6.  Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.

Authors:  Kamal Albarazanji; Matthew Jennis; Cassandre R Cavanaugh; Wensheng Lang; Bhanu Singh; James C Lanter; James M Lenhard; Pamela J Hornby
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

7.  Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.

Authors:  C Scarpignato; G Varga; I Dobronyi; M Papp
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

8.  Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA.

Authors:  N Sazaki; K Miyasaka; M Matsumoto; A Funakoshi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

9.  Changes in gene expression of cholecystokinin-A receptor after induction of pancreatitis by pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

Review 10.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.